Harrow (HROW) Price to FCF (2010 - 2026)
Harrow (HROW) posted Price to FCF of 155.37 for Q2 2026, down 8.61% on a QoQ basis from 143.06 in Q1 2026, and up 86.57% year-over-year from 83.28 in Q2 2025.
Analysis
Harrow (HROW) Price to FCF (2010 - 2026) Analysis & Trends
Harrow has reported Price to FCF for 17 years, with the latest figure at 155.37 in Q2 2026.
- On a quarterly basis, Price to FCF rose 86.57% year-over-year to 155.37 in Q2 2026; TTM through Jun 2026 was 317.38, a 28.05% decrease from a year earlier, with the FY2025 full-year figure at 42.45, up 184.52% from the prior year.
- Price to FCF was 155.37 for Q2 2026 at Harrow, down from 143.06 in the prior quarter.
- The five-year high for Price to FCF was 682.18 in Q3 2024, with the low at 1157.14 in Q2 2025.
- Average Price to FCF over 5 years is 51.56, with a median of 69.1 recorded in 2023.
- The sharpest annual moves came in 2022 and 2026: Price to FCF surged 459.53% in 2022, then plunged 394.11% in 2026.
- Over 5 years, Price to FCF stood at 96.15 in 2022, then surged by 148.18% to 46.33 in 2023, then sank by 240.7% to 65.19 in 2024, then surged by 446.78% to 226.05 in 2025, then tumbled by 168.73% to 155.37 in 2026.
- The last three Price to FCF figures came in at 155.37 (Q2 2026), 143.06 (Q1 2026), and 226.05 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.62 Bn | 625.86 Bn | 17.26 Bn |
| 2 | AbbVie | 442.20 Bn | 435.63 Bn | 12.70 Bn |
| 3 | Merck | 366.42 Bn | 359.28 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.80 Bn | 259.11 Bn | 11.24 Bn |
| 5 | Pfizer | 159.12 Bn | 147.42 Bn | 10.94 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.39 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.45 Bn | 18.78 Bn | 683.80 Mn |
| 10 | Harrow | 1.41 Bn | 1.32 Bn | 50.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -155.37 |
| Mar 31, 2026 | -143.06 |
| Dec 31, 2025 | 226.05 |
| Sep 30, 2025 | 108.95 |
| Jun 30, 2025 | -1,157.14 |
| Mar 31, 2025 | 48.64 |
| Dec 31, 2024 | -65.19 |
| Sep 30, 2024 | 682.18 |
| Jun 30, 2024 | -239.86 |
| Mar 31, 2024 | -99.17 |
| Dec 31, 2023 | 46.33 |
| Sep 30, 2023 | -292.04 |
| Jun 30, 2023 | 133.57 |
| Mar 31, 2023 | -73.02 |
| Dec 31, 2022 | -96.15 |
| Sep 30, 2022 | -223.06 |
| Jun 30, 2022 | 42.84 |
| Mar 31, 2022 | 327.45 |
| Dec 31, 2021 | -142.86 |
| Sep 30, 2021 | -103.40 |